Adlai Nortye Signs Lilly and Merck Trial Agreements for AN4035
Adlai Nortye said the clinical-trial collaboration and supply agreements will support its Phase 1 trial of AN4035, which is being developed to treat certain tumors.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.